Clinical Trial Update: N-acetyl-cysteine (NAC) and Kidney Graft Function [Phase 3]

View source ↗

Summary

Phase 3 trial assessing N-acetyl-cysteine for kidney graft function has completed, with the sponsor listed as Institut d'Anesthesiologie des Alpes Maritimes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation
• Renal Failure

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Institut d'Anesthesiologie des Alpes Maritimes | Conditions: Brain Death, Chronic Renal Insufficiency | Phase 3 | Status: COMPLETED